Drug resistance inMycobacterium lepraefrom patients with leprosy in China
Clinical and Experimental Dermatology2015Vol. 40(8), pp. 908–911
Citations Over Time
Dong Liu, Qinghe Zhang, Yonghu Sun, C. Wang, Yi Zhang, Xi’an Fu, M. Chen, Guilan Zhou, Xiaofei Yu, J. Wang, Hong Liu, Furen Zhang
Abstract
Primary resistance appears to be to either single drugs or combinations of two drugs. The resistance rate to dapsone seems to be low. To our knowledge, this is the first case of multidrug-resistant M. leprae from China.
Related Papers
- Susceptibility of strains of Mycobacterium leprae isolated prior to 1977 from patients with previously untreated lepromatous leprosy.(1986)
- Multiple mutations in the rpoB gene of Mycobacterium leprae strains from leprosy patients in Thailand.(2000)
- Adenosine triphosphate content of Mycobacterium leprae from leprosy patients.(1984)
- → Primary dapsone-resistant Hansen's disease in California. Experience with over 100 Mycobacterium leprae isolates(1990)11 cited
- Activity of the combination of isoniazid, protionamide and dapsone against Mycobacterium leprae and some other mycobacteria.(1981)